The Digital Trap: Breaking Free From the Grip of Electronic Tethers

"You said no to the vaccine. Now you need to start saying no to these electronic tethers," stressed attorney W. Scott McCollough.

"Every time you download an app ... you're giving them permission to look at your contact list. You're giving them permission to look at the files," he denoted.

"If you start limiting their ability to get the data, then they will have a harder time instituting the control state because there will be gaps in the data that they need."

Wonder Week 16 Release

The song remains the same

Increase from 19.9% to 20.5% excess mortality from cancer in younger ages over the last 5 weeks.

Not Covid
Not model tweaks
Not Long Covid
Not deferred screenings...

@EthicalSkeptic

https://historyheist.com/council-of-europe-chair-says-pharmaceutical-companies-conspired-with-who-to-make-vast-profits-from-fake-swine-flu-hysteria/

This is about the 2009 swine flu “pandemic” that also was never a real pandemic.

The German public health doctor, Wolfgang Wodarg, discovered the fraud by accident and just kept digging.

It’s my hunch that the true purpose was a final dress rehearsal for a number of components of what we’re now living in, possibly PCR mass testing.

Best wishes
Mike

"Bridgen Announces He's Suing Matt Hancock for Defamation"

https://youtu.be/hezGmSPDIt4

Andrew Bridgen is joining Laurence Fox's Reclaim Party as the party's first MP.

https://www.itv.com/news/central/2023-05-10/andrew-bridgen-mp-formally-joins-laurence-foxs-reclaim-party

"Suddenly changed? Personality-changes after mRNA-Injection?"

https://video.icic-net.com/w/18907e79-a065-4f6e-853e-3c6c2e859a46

April 13, 2023:

"At least 19 million doses of COVID-19 vaccines are set to expire by the end of the year in Canada, according to data received by The Canadian Press.

The federal central inventory currently has 18.5 million doses in stock, with 16.8 million of those bearing 2023 expiry dates, the Public Health Agency of Canada said.

There are more than eight million additional doses in provincial and territorial stockpiles, according to data provided by ministries and departments of health across the country.

Those numbers show more than two million of the provincial and territorial doses will expire by the end of the year.

However, that’s likely an underestimate because Ontario, New Brunswick and P.E.I. did not disclose the proportion of their doses that would expire by year-end. Ontario alone has 4.8 million COVID-19 vaccine doses in its supply."

https://globalnews.ca/news/9620497/covid-vaccines-expiry-2023/

May 4, 2023:

"Vaccines manufactured at Moderna's state-of-the-art Canadian mRNA facility to be prepared and packaged at Novocol's Ontario-based facility

Fill-finish agreement will secure domestic end-to-end vaccine production and ensures rapid response capabilities for future pandemic readiness for Canadians...

Moderna's mRNA pipeline includes 47 programs, including vaccines against respiratory viruses, vaccines against latent viruses, and vaccines against threats to global public health."

https://www.newswire.ca/news-releases/moderna-and-novocol-pharma-announce-fill-finish-agreement-for-canadian-made-mrna-vaccines-890291200.html

Genetic Engineering & Biotechnology News

"Already notable for developing mRNA therapeutics and for introducing a breakthrough vaccine against COVID-19, Moderna now has RSV in its sights. “Our success with COVID-19 enabled us to attract a tremendous pool of talent and expertise which has enabled rapid RSV development,” says David Martin, MD, MPH, vice president, global head of medical RWE, Moderna. “Furthermore, regulators and other health authorities around the globe are familiar with the mRNA platform technology...

Moderna’s candidate, mRNA-1345, consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein complex and employs the same lipid nanoparticles used in its COVID-19 vaccines...

Passive vaccination

“Vaccines have provided incredible public health benefits against many different infectious diseases. [This success is due to] traditional vaccines, which represent active measures that induce the host to make antibodies against the disease being targeted,” points out Kevin Russell, MD, MTMH, section head, pediatric portfolio, global clinical research, Merck Research Laboratories. “However, in the case of RSV, the challenge for newborns or premature babies is that they don’t have an adequate or mature enough immune system to respond well to traditional active vaccinations. That’s where passive vaccination with monoclonal antibodies (mAbs) can play a role.

'The advantage of passive vaccination is that its onset is immediate. You don’t have to wait for the immune system to create the antibodies for protection. It also provides very specific protection since mAbs can be designed only to attack and neutralize the infectious agent—in this case, RSV.'"

https://www.genengnews.com/topics/translational-medicine/infectious-diseases/multiple-vaccine-technologies-converge-on-respiratory-syncytial-virus/

May 5, 2023

"The company will submit the vaccine for regulatory approval for adult patients in early 2023 and has fully enrolled Phase 1 studies to evaluate mRNA-1345's tolerance and safety in children."

https://www.contemporarypediatrics.com/view/a-look-at-what-is-in-the-pipeline-for-rsv-vaccines-for-children

May 6, 2023

"Is Moderna Building a Respiratory Vaccine Empire?"

"The future of the coronavirus program

"First, let's consider what's set to happen with the coronavirus vaccine program. Yes, product revenue won't match the $18.4 billion of last year. Moderna predicts at least $5 billion, according to coronavirus vaccine contracts signed so far.

That figure could move higher though, as Moderna still is negotiating potential contracts with pharmacies, hospital systems, and others. As we head toward a post-pandemic situation, the company will sign deals with these private players instead of with the government. In this private market, the price of Moderna's vaccine will move higher, too -- possibly reaching as much as $130 a dose.

Moderna sees this market following that of the flu, with people going back for annual boosters. This is positive because it represents a source of recurrent revenue. The company forecasts a coronavirus market of $15 billion. This season's coronavirus hospitalization rate has been almost triple that of the flu. So, it's very likely those who go for a flu vaccine will want protection from the coronavirus too.

But Moderna isn't stopping here. The company is aiming to launch vaccine products across coronavirus, flu, and respiratory syncytial virus (RSV) -- and reap major rewards as early as 2027."

https://www.theglobeandmail.com/investing/markets/stocks/MRNA-Q/pressreleases/16655204/is-moderna-building-a-respiratory-vaccine-empire/

"The Moderna mRNA pipeline"

"Our mRNA pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions."

https://www.modernatx.com/research/product-pipeline

RFK Jr. Shakes Up Big Pharma With the Inconvenient Truth About Mass Shootings

"Anecdotally, it appears that almost every one of these shooters were on SSRIs or some other psychiatric drug. And this is only happening in America where ... we take four times as many [psychiatric drugs] as the average European country." stated Mr. Kennedy.

"Prior to the introduction of Prozac, those shootings just were almost unknown, and now they're an everyday affair. But NIH will not study that because it will offend the pharmaceutical industry. And it's something that we ought to be studying."

H/T: @UngaTheGreat (Give him a follow)

Retweet: https://twitter.com/VigilantFox/status/1656286532083519488?s=20

Full Interview: https://www.steynonline.com/13463/rfk-jr-runs-for-president

Follow @VigilantFox 🦊
Rumble | Substack | Socials

OnLabor website: "For Slaughterhouse Workers, Physical Injuries Are Only the Beginning"

Excerpt:

"Working in a stressful and potentially unsafe environment can, on its own, impact a worker’s mental health. However, as many researchers have noted, slaughterhouse work remains distinct from other dangerous industrial jobs in that the nature of the work itself is violent, and thus may inherently cause psychological distress or harm. Some slaughterhouse workers have discussed feeling the need to disassociate themselves from their work in order to suppress feelings of guilt when committing violent acts. Others have expressed increased feelings of aggression while working on the killing floor. These anecdotal reports from workers are borne out by academic research; slaughterhouse work has been linked to higher levels of aggression, violent dreams, anxiety, and hostility. Some researchers have categorized the psychological symptoms experienced by slaughterhouse employees as a form of trauma disorder, such as Post-Traumatic Stress Disorder (PTSD) or the more seldom-discussed Perpetration-Induced Traumatic Stress (PITS). As a whole, slaughterhouse workers experience significantly higher levels of serious psychological distress (SPD) than the general population." [Jan 17, 2022]

May 8, 2023

"Slaughterhouse cleaning company employed children: How hiring went wrong"

https://www.cbs.com/shows/video/wLpYw_plKZfjRw5cyC8e2NJiXXwqlFXY/

F O L L O W

Y O U R

I N T U I T I O N

N O T

T H E

"S C I E N C E"


@RobinMG

History repeats, by weaponising older history, to repeat the same patterns, while disguising them:

Dr. Bhakdi’s Legal Case – Doctors for COVID Ethics
https://doctors4covidethics.org/dr-bhakdis-legal-case/

Amazing that a two minute clip of video taken a few weeks ago has led to Lifesite News #1 item today, ensuring a large readership, some of whom, perhaps, did not yet know this information.
Thank you LSN,
Mike

https://www.lifesitenews.com/news/ex-pfizer-vp-covid-vax-push-a-supranational-operation-intended-to-maim-and-kill-deliberately/